Navigation Links
Complications early in pregnancy or in previous pregnancies adversely affect existing or subsequent pregnancies
Date:6/28/2009

monitoring in high risk pregnancies it is possible to reduce perinatal or postnatal foetal complications. For example, in pregnancies with increased risk of preterm or very preterm delivery or intrauterine growth restriction, extra ultrasonic measurement of the cervical length and foetal growth can provide a better prediction of pregnancies at risk and better therapeutic care can be given, such as bed rest, corticosteroids and monitoring of the baby's heart beat. Furthermore, by identifying high-risk patients, this could enable new research for improved clinical management.

"Events and complications in early pregnancy are amongst the most common complications in women during their pregnancy and can be extremely distressing for them. For the clinician it is important to interpret the symptoms and to understand not only the short-term consequences, but also the long-term consequences of these early pregnancy complications. This is especially important for reassuring and supporting the couple at a difficult time.

"More large controlled studies, using local National Birth Registries, are needed to confirm our findings. In particular, larger studies concerning the risk of adverse late pregnancy outcome in women presenting with unexplained recurrent miscarriage, intrauterine haematoma and a smaller than expected foetus are needed."


'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. MIT: Novel needle could cut medical complications
2. Project aims to reduce complications, multiple surgeries with biodegradable implantable devices
3. Herpes virus link to complications in pregnancy
4. Study shows Chronix technology using serum DNA can identify early presence of disease
5. Major breakthrough in early detection and prevention of AMD
6. Early identification of dementia increasingly difficult
7. New early detection studies of lung cancer in non-smokers launched today
8. Personalized treatment for early lung cancer
9. Early detection of lung cancer: New data presented at multidisciplinary meeting
10. Google Earth aids discovery of early African mammal fossils
11. Early brain activity sheds new light on the neural basis of reading
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... team of researchers from The Chinese University of Hong ... of wild soybean linked to salt tolerance, with implication ... soil. This study published online in Nature Communications ... information for crop improvement. , Soybean is an important ... selection, cultivated soybeans have less genetic diversities than their ...
(Date:7/11/2014)... July 11, 2014 Researchers have pioneered ... images. The new technology, called Virtual Finger, allows ... structures like neurons and synapses using the flat ... technology makes 3D imaging studies orders of magnitude ... an unprecedented level across many areas of experimental ...
(Date:7/11/2014)... 1 can inhibit voltage-gated calcium channel, decrease ... However, some scholars demonstrated that cannabinoid receptor ... and increase neurotransmitter release. Dr. Yi Zhang ... Tongji Medical College, Huazhong University of Science ... and calcium imaging in cultured trigeminal ganglion ...
Breaking Biology News(10 mins):BGI reports a novel gene for salt tolerance found in wild soybean 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... , This release is available in French ... there has been a huge amount of groundwater pollution worldwide, ... water supply," says Barbara Sherwood Lollar, Canada Research Chair in ... University of Toronto. Sherwood Lollar is taking part ...
... generation of sensors with applications ranging from medical ... Liu looks to biology. Liu, professor of mechanical ... University,s McCormick School of Engineering and Applied Science, is ... and flow sensors areas that currently lack good ...
... The arrival of affordable, high throughput DNA sequencing, coupled ... major advances in the field of molecular plant breeding. ... are able to investigate genome-wide variations in DNA sequences ... traits controlled by many genes, such as hybrid vigor. ...
Cached Biology News:Water, water, everywhere… but is it safe to drink? 2Turning to nature for inspiration 2
(Date:7/11/2014)... MISSISSAUGA, ON , July 11, 2014 /CNW/ - ... Canada approved APTIOM TM (eslicarbazepine acetate) for use ... partial-onset seizures in patients with epilepsy who are not ... not indicated for use in patients under 18 years ... the most common neurological disorders and according to Epilepsy ...
(Date:7/10/2014)... July 10, 2014 Women in ... access to an additional family planning option. Sayana® ... contraception at all levels of the health system ... of a widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone ... Faso is the first of four African countries ...
(Date:7/10/2014)... Ohio (PRWEB) July 10, 2014 Understanding ... ion channel-expressing cell lines, and the gap that currently ... cells that expand its industry-leading portfolio of validated ion ... on ion channel-expressing cell lines, as ion channels control ... to control this activity creates the potential to treat ...
(Date:7/10/2014)... 10, 2014 Robert Harman, DVM, Founder and ... is proud to announce the relaunch of his highly informative ... new series called “ What are Stem Cells ?” ... and straightforward foundation in the basics of stem cell therapy ... the right type of treatment when considering regenerative medicine. , ...
Breaking Biology Technology:Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3
... a researcher, please contact the Communications and External Relations staff ... information on ORNL and its research and development activities, please ... a general media-related question or comment, you can send it ... Intelligent intelligence . . . In combat situations, ...
... full day with the announcement of the 2010 Kavli ... by Harold Varmus, co-chair of President Obama,s Council of ... live simulcast of the announcement of the laureates by ... Norway. A panel discussion follows, moderated by Elizabeth ...
... Calif. , May 21 Abviva, Inc. (Pink Sheets: ... breast cancer related applications of Mammastatin, today provided further details about ... , , , ... previously announced that the Japanese Patent Office issued two patents on ...
Cached Biology Technology:Story tips from the Department of Energy's Oak Ridge National Laboratory May 2010 2Story tips from the Department of Energy's Oak Ridge National Laboratory May 2010 3Abviva Details Patent Information for its Breast Cancer Risk Assessment Technology 2Abviva Details Patent Information for its Breast Cancer Risk Assessment Technology 3
Sheep polyclonal to Malate Dehydrogenase ( Abpromise for all tested applications). Antigen: Full length protein - Pig heart malate dehydrogenase. Entrez Gene ID: 4190 Swiss Protein ID: P...
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... transporter 2 (APT2) (Peptide ... PSF2) (Peptide supply factor ... involved in antigen processing ... Antigen: Recombinant ...
Raised to arginine vasopressin coupled to bovine thyroglobulin with carbodiimide ....
Biology Products: